The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma-Reference-Cited by-同舟云学术

The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma

Published:2013-06-21 Issue:10 Volume:133 Page:2277-2283
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhuang Hongqing¹,Wang Jun¹,Zhao Lujun¹,Yuan Zhiyong¹,Wang Ping¹

Affiliation:

1. Department of Radiotherapy, Tianjin Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy; and Tianjin Lung Cancer Center; Tianjin; PR; China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference48 articles.

1. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial;Aoyama;JAMA,2006

2. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy;Lagerwaard;Int J Radiat Oncol Biol Phys,2009

3. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors;Lee;J Clin Neurosci,2009

4. Second-line treatments in non-small cell lung cancer. A systematic review of literature and metaanalysis of randomized clinical trials;Tassinari;Chest,2009

5. Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice;Tassinari;Ann Oncol,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases;Brain Sciences;2023-09-03

2. Optimal timing of hypofractionated stereotactic radiotherapy for epidermal growth factor receptor‐mutated non‐small‐cell lung cancer patients with brain metastases;Asia-Pacific Journal of Clinical Oncology;2023-04-23

3. Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis;Annals of Translational Medicine;2021-03

4. Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling;Life Sciences;2020-10

5. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases;BMC Cancer;2020-09-03